Corporate Update – October 2026
British American Tobacco plc (BAT) has reported a series of routine corporate actions during October 2026, primarily concerning share‑level activity and capital structure adjustments. The company confirmed the issuance and allotment of new ordinary shares through its Sharesave scheme from 1 September to 30 September, bringing the total issued share capital to just over 2.15 billion shares with voting rights, while maintaining a treasury balance of roughly 132 million shares. These issuances were fully fungible with existing shares and were admitted to trading on the London Stock Exchange under an existing block admission.
In addition to the share issue, BAT executed a buy‑back programme that purchased and cancelled ordinary shares held by Goldman Sachs International during a five‑day window in late August. The repurchase was carried out at prices that varied modestly across the trading days, reflecting typical market conditions for a large listed issuer. Following the buy‑back, the company’s share count and treasury holdings were updated to reflect the cancelled shares.
BAT also announced a series of related‑party transactions involving senior executives and close associates. These disclosures included the granting of ordinary shares as part of a restricted share plan, with vesting schedules extending into the next several years. The awards were priced at the prevailing market level and were structured to provide incentives aligned with the company’s long‑term objectives.
The company’s financial reporting for the period remained consistent with prior releases. Dividend declarations and capital management strategies were reiterated, with no significant changes to payout policy noted. Market‑level commentary indicated that BAT’s share price continued to trade within the lower end of the broader index range, reflecting broader market volatility rather than company‑specific developments.
Overall, the updates highlighted BAT’s ongoing commitment to shareholder value through share buy‑backs, disciplined capital allocation, and transparent governance practices.
